[Digitalization of the arrhythmic heart patient].
Digitalis combines a longstanding tradition with constant up-to-dateness. Kinetic maintenance therapy is very often required for heart patients with arrhythmia as one of their most striking clinical manifestations. The well-known questions of paroxystic tachycardia, flutter and atrial fibrillation are examined, and attention is concentrated on ventricular extrasystole, sinoatrial node disease, and Wolff-Parkinson-White syndrome. It is clear that combinations with recently introduced antiarrhythmic drugs, and administration of diuretics and electrolytes, and the employment of electrical stimulation have facilitated the long-term treatment of the chronic arrhythmic heart patient and brought about the better utilisation of digitalic substances. Their arrhythmogenic potential, however, cannot be overlooked.
D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D004071:Digitalis Glycosides / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006321:Heart / Q000187:drug effects; D006327:Heart Block / Q000188:drug therapy; D006801:Humans; D007700:Kinetics; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy
D004071:Digitalis Glycosides
La digitalizzazione del cardiopaziente aritmico.